argenx SE (ARGX)
USD 558.55
(-5.34%)
USD 558.55
(-5.34%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.02 Billion USD | -157.36% |
| 2022 | -788.31 Million USD | 40.42% |
| 2021 | -1.32 Billion USD | -9.36% |
| 2020 | -1.2 Billion EUR | -232.59% |
| 2019 | -363.79 Million EUR | -13.16% |
| 2018 | -321.48 Million EUR | -40.4% |
| 2017 | -228.98 Million EUR | -142.2% |
| 2016 | -94.54 Million EUR | -143.5% |
| 2015 | -38.82 Million EUR | 0.78% |
| 2014 | -39.13 Million EUR | -24.73% |
| 2013 | -31.37 Million EUR | -72.68% |
| 2012 | -18.16 Million EUR | 35.85% |
| 2011 | -28.32 Million EUR | -169.71% |
| 2010 | -10.5 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.4 Billion USD | -147.66% |
| 2024 Q1 | 2.94 Billion USD | 245.24% |
| 2023 Q2 | -1.09 Billion USD | -154.39% |
| 2023 FY | -2.02 Billion USD | -157.36% |
| 2023 Q4 | -2.02 Billion USD | -207.41% |
| 2023 Q3 | 1.88 Billion USD | 271.83% |
| 2023 Q1 | 2.02 Billion USD | 356.41% |
| 2022 Q2 | -1.35 Billion USD | 0.0% |
| 2022 FY | -788.31 Million USD | 40.42% |
| 2022 Q4 | -788.31 Million USD | -129.74% |
| 2022 Q3 | 2.65 Billion USD | 295.25% |
| 2021 Q4 | -1.32 Billion USD | 0.0% |
| 2021 Q2 | -1.57 Billion USD | 0.0% |
| 2021 FY | -1.32 Billion USD | -9.36% |
| 2020 Q2 | -1.34 Billion EUR | 0.0% |
| 2020 FY | -1.2 Billion EUR | -232.59% |
| 2020 Q4 | -1.2 Billion EUR | 0.0% |
| 2019 Q4 | -324.76 Million EUR | 0.0% |
| 2019 FY | -363.79 Million EUR | -13.16% |
| 2019 Q2 | -186.58 Million EUR | 0.0% |
| 2018 Q2 | -162.87 Million EUR | 0.0% |
| 2018 Q4 | -321.48 Million EUR | 0.0% |
| 2018 FY | -321.48 Million EUR | -40.4% |
| 2017 Q2 | -86.4 Million EUR | 0.0% |
| 2017 Q4 | -228.98 Million EUR | 0.0% |
| 2017 FY | -228.98 Million EUR | -142.2% |
| 2016 FY | -94.54 Million EUR | -143.5% |
| 2016 Q4 | -94.54 Million EUR | 0.0% |
| 2016 Q2 | -113.36 Million EUR | 0.0% |
| 2015 Q2 | -29.39 Million EUR | 0.0% |
| 2015 FY | -38.82 Million EUR | 0.78% |
| 2015 Q4 | -38.82 Million EUR | 0.0% |
| 2014 Q1 | -28.07 Million EUR | 10.51% |
| 2014 Q2 | -28.15 Million EUR | -0.29% |
| 2014 Q4 | -39.13 Million EUR | 0.0% |
| 2014 FY | -39.13 Million EUR | -24.73% |
| 2013 FY | -31.37 Million EUR | -72.68% |
| 2013 Q4 | -31.37 Million EUR | 0.0% |
| 2012 FY | -18.16 Million EUR | 35.85% |
| 2011 FY | -28.32 Million EUR | -169.71% |
| 2010 FY | -10.5 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -3526.822% |
| Alkermes plc | -166.73 Million USD | -1116.778% |
| Agenus Inc. | 274.13 Million USD | 840.087% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 208.498% |
| Aptorum Group Limited | 1.35 Million USD | 149604.438% |
| Ardelyx, Inc. | 34.51 Million USD | 5978.662% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 47502.897% |
| Bicycle Therapeutics plc | -481.46 Million USD | -321.388% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 5710.276% |
| ChromaDex Corporation | -24.04 Million USD | -8336.643% |
| Chimerix, Inc. | -25.51 Million USD | -7850.95% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 29216.273% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -8468.839% |
| CRISPR Therapeutics AG | -150.84 Million USD | -1244.986% |
| Precision BioSciences, Inc. | -85.41 Million USD | -2275.417% |
| Dyadic International, Inc. | -6.37 Million USD | -31709.541% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -12633.597% |
| Fortress Biotech, Inc. | 7.66 Million USD | 26568.937% |
| Lantern Pharma Inc. | -21.7 Million USD | -9248.099% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -1735.443% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -23648.124% |
| Incyte Corporation | -3.17 Billion USD | 36.101% |
| IO Biotech, Inc. | -140.69 Million USD | -1341.975% |
| Jaguar Health, Inc. | 29.39 Million USD | 7002.943% |
| Novavax, Inc. | -298.29 Million USD | -580.149% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 38114.69% |
| Opthea Limited | 28.15 Million USD | 7305.355% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -11984.365% |
| ContextLogic Inc. | -232 Million USD | -774.502% |
| MiMedx Group, Inc. | -33.9 Million USD | -5884.614% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 20000.383% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -87462.381% |
| NextCure, Inc. | -6.47 Million USD | -31223.823% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -3917.433% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -31705.048% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 16780.091% |
| Vaxcyte, Inc. | -368.22 Million USD | -450.976% |
| PDS Biotechnology Corporation | -32.7 Million USD | -6102.728% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 11842.354% |
| Pharming Group N.V. | 109.8 Million USD | 1947.696% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -11562.704% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -1057.818% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -10854.966% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -10854.966% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -28475.268% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -34521.911% |
| Acelyrin, Inc. | -216.9 Million USD | -835.369% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -36063.056% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -117582.367% |
| Summit Therapeutics Inc. | 34.67 Million USD | 5951.197% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -29722.784% |
| Senti Biosciences, Inc. | 1.74 Million USD | 116700.23% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -999.007% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -2519.519% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -33368.228% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 2033641.481% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 323164.331% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -1633.373% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -1105.973% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 1929.931% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -26609.373% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -1471.359% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 29526.574% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -737.11% |
| Immix Biopharma, Inc. | -17.5 Million USD | -11486.912% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -540.614% |
| MEI Pharma, Inc. | -3.7 Million USD | -54659.622% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 16316.481% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 1354.371% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 7399.838% |
| Fortress Biotech, Inc. | 7.66 Million USD | 26568.937% |
| Precigen, Inc. | -481 Thousand USD | -421697.089% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 14508.38% |
| AlloVir, Inc. | -62.69 Million USD | -3136.209% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -3548.081% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 3390.053% |
| ImmuCell Corporation | 10.99 Million USD | 18559.875% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -1216.183% |
| Onconetix, Inc. | 5.33 Million USD | 38154.356% |
| PureTech Health plc | -167.19 Million USD | -1113.445% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -6560.683% |
| Elevation Oncology, Inc. | -19.11 Million USD | -10512.219% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -41229.069% |
| Seer, Inc. | -4.24 Million USD | -47750.094% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -8340.504% |
| Innoviva, Inc. | 255.56 Million USD | 893.872% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -3531.756% |
| ESSA Pharma Inc. | -33.62 Million USD | -5934.35% |
| GlycoMimetics, Inc. | -40.98 Million USD | -4850.28% |
| GT Biopharma, Inc. | -1.02 Million USD | -198611.459% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -2893.146% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 3412.02% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -1413.171% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -14542.35% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -6927.03% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -2693031.919% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -6473.923% |
| Aptose Biosciences Inc. | -8.19 Million USD | -24657.528% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -64739.64% |
| Soligenix, Inc. | -4.95 Million USD | -40873.528% |
| Century Therapeutics, Inc. | 847 Thousand USD | 239632.94% |
| Kura Oncology, Inc. | -20.11 Million USD | -9984.72% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -4857.347% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -24058.657% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 111471.223% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -63360.87% |
| Autolus Therapeutics plc | -186.59 Million USD | -987.275% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -4014.968% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -635.637% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 6020.521% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 1334.33% |
| GRI Bio, Inc. | -1.79 Million USD | -112990.524% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -22485.257% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -6000.502% |
| IGM Biosciences, Inc. | -72.6 Million USD | -2694.32% |
| INmune Bio, Inc. | -25.41 Million USD | -7884.117% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 1444.041% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -3904.903% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -12385.676% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -70225.686% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 5436.956% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -4826.172% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 6463.005% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 636.801% |
| Verastem, Inc. | -37.27 Million USD | -5342.47% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -22261.336% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -3812.005% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -13304.982% |
| Histogen Inc. | -7.48 Million USD | -26998.224% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -9289.832% |
| Surrozen, Inc. | -32.66 Million USD | -6111.254% |
| Organovo Holdings, Inc. | -1.5 Million USD | -134528.003% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -48165.726% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 10800.537% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 77655.199% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 48917.228% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -24107.227% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -4570.236% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -13818.251% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -540.44% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -280879.974% |
| Apollomics, Inc. | -27.39 Million USD | -7305.892% |
| Amarin Corporation plc | -191.04 Million USD | -962.0% |
| Mesoblast Limited | 55.96 Million USD | 3725.331% |
| Turnstone Biologics Corp. | -14.58 Million USD | -13811.437% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -7921.683% |
| Synaptogenix, Inc. | -28.66 Million USD | -6978.639% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -216656.838% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 4263.268% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -235240.435% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -27822.126% |
| Exelixis, Inc. | -73.05 Million USD | -2677.336% |
| Better Therapeutics, Inc. | -860 Thousand USD | -235812.093% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -8348.94% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -740.55% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 275733.435% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -27176.246% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 161889.793% |
| Gritstone bio, Inc. | 39.49 Million USD | 5237.615% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -2312.39% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -76979.639% |
| Avid Bioservices, Inc. | 169.72 Million USD | 1295.35% |
| Insmed Incorporated | 721.62 Million USD | 381.151% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -22093.747% |
| MediWound Ltd. | -5.32 Million USD | -38021.834% |
| OmniAb, Inc. | 9.2 Million USD | 22145.463% |
| Alector, Inc. | -35.63 Million USD | -5593.083% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 2459.917% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -41069.724% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 15424.753% |
| Zai Lab Limited | -775 Million USD | -161.786% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 695.746% |
| Aura Biosciences, Inc. | -21.52 Million USD | -9325.524% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -2359.801% |
| Immunic, Inc. | -45.34 Million USD | -4374.733% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -950.045% |
| Veracyte, Inc. | -203.82 Million USD | -895.39% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 417.854% |
| FibroGen, Inc. | 56.76 Million USD | 3673.985% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 22883.2% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -71664.597% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -97895.313% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 144.198% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -60625.651% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -1122.46% |
| TG Therapeutics, Inc. | 17.86 Million USD | 11458.437% |
| Galecto, Inc. | -21.21 Million USD | -9462.802% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -8429.931% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 229.275% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -8190.471% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -17531.39% |
| XBiotech Inc. | -200.02 Million USD | -914.305% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -2312.39% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 44906.625% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -5653.464% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -2527.424% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 35750.044% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -1090.531% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -2096.337% |
| Vaxxinity, Inc. | 10.13 Million USD | 20124.122% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 375.559% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -18742.205% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -2976.057% |
| NexImmune, Inc. | -3.13 Million USD | -64643.942% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -58661.545% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -13325.872% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -7386.509% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -22502.852% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -1628512.482% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -4900.601% |
| Ainos, Inc. | 4.07 Million USD | 49851.835% |
| Pluri Inc. | 22.82 Million USD | 8987.135% |
| Prothena Corporation plc | -608.34 Million USD | -233.501% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -1608.414% |
| Celularity Inc. | 65.19 Million USD | 3212.201% |
| Rallybio Corporation | -24.1 Million USD | -8317.741% |
| Cue Biopharma, Inc. | -33.81 Million USD | -5899.125% |
| MeiraGTx Holdings plc | -40.3 Million USD | -4934.103% |
| Omeros Corporation | 331.17 Million USD | 712.618% |
| Humacyte, Inc. | -22.48 Million USD | -8922.699% |
| Immunocore Holdings plc | -358.59 Million USD | -465.777% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -8155.723% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -6465.626% |
| Blueprint Medicines Corporation | 702.83 Million USD | 388.665% |
| CalciMedica, Inc. | -5.53 Million USD | -36587.957% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -977.911% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -19763.364% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -4967.423% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -6001.236% |
| Pulmatrix, Inc. | -10.41 Million USD | -19376.279% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -33844.186% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -5219.186% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -1721.192% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -3284.565% |
| Cytokinetics, Incorporated | 642.37 Million USD | 415.836% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -34741.903% |
| Nutriband Inc. | -251.65 Thousand USD | -806094.145% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -5846.376% |
| Vor Biopharma Inc. | 4.3 Million USD | 47282.419% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 66.387% |
| Evogene Ltd. | -19.63 Million USD | -10233.32% |
| ProKidney Corp. | -56.23 Million USD | -3507.732% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -4068.401% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -21863.873% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 248.753% |
| CorMedix Inc. | -43.05 Million USD | -4612.488% |
| BioLineRx Ltd. | 7.33 Million USD | 27755.998% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -7287.016% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 4496.481% |
| Atai Life Sciences N.V. | -28.55 Million USD | -7004.293% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 91057.975% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -8792.198% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 11539.774% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -2602.459% |
| MediciNova, Inc. | -50.78 Million USD | -3895.084% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -2474.512% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -9018988.686% |
| GeoVax Labs, Inc. | -6.45 Million USD | -31342.325% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -915.331% |
| Biomea Fusion, Inc. | -166.57 Million USD | -1118.013% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -1033.591% |
| Mereo BioPharma Group plc | -51.46 Million USD | -3841.876% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -2039.138% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -590.649% |
| Absci Corporation | -72.59 Million USD | -2694.628% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 44533.728% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -765.411% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -2053.511% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -2020.093% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -5092.445% |
| Allakos Inc. | -24.97 Million USD | -8023.499% |
| Imunon, Inc. | -4.21 Million USD | -48047.016% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -13662.339% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -1398.408% |
| BioAtla, Inc. | -109.01 Million USD | -1761.137% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 275733.435% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -215964.324% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 17055.073% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -9468.665% |
| XOMA Corporation | -29 Million USD | -6896.014% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -12151.473% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -22402.706% |
| aTyr Pharma, Inc. | -7.44 Million USD | -27136.461% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -1527.815% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -874.637% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -2380.886% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -2087.126% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -236036.148% |
| Akari Therapeutics, Plc | -3.84 Million USD | -52665.774% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 125114.265% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 246.924% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -170658.71% |
| UroGen Pharma Ltd. | 4.39 Million USD | 46304.6% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 1887.827% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 2819426.867% |
| Orgenesis Inc. | 21.78 Million USD | 9413.459% |
| Entera Bio Ltd. | -10.62 Million USD | -18987.816% |
| GH Research PLC | -78.07 Million USD | -2498.517% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -9002.854% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -7510.353% |
| Xencor, Inc. | 29.64 Million USD | 6944.029% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -102896.834% |
| Replimune Group, Inc. | 1.41 Million USD | 143785.836% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -828310.668% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -1504.882% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -170658.71% |
| Portage Biotech Inc. | -4.98 Million USD | -40631.66% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -9018988.686% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -2968.334% |
| OncoCyte Corporation | -6.56 Million USD | -30813.363% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 226176.957% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -44434.745% |
| Purple Biotech Ltd. | -14.13 Million USD | -14250.29% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -8440.343% |
| scPharmaceuticals Inc. | -6.54 Million USD | -30898.38% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -12054.469% |
| HilleVax, Inc. | -165.48 Million USD | -1125.999% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -79838.692% |
| Tharimmune, Inc. | -10.93 Million USD | -18453.074% |
| Genprex, Inc. | -6.73 Million USD | -30012.136% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -450.11% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -2193.516% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -144713.99% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -61066.024% |
| OKYO Pharma Limited | -826.84 Thousand USD | -245270.854% |
| Savara Inc. | 153 Thousand USD | 1326141.83% |
| Curis, Inc. | -23.88 Million USD | -8393.507% |
| Daré Bioscience, Inc. | -5.15 Million USD | -39234.607% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -261344.926% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -32581.121% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 171310.464% |
| BeiGene, Ltd. | -2.25 Billion USD | 9.953% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 16543.198% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -233.58% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -993.21% |
| Erasca, Inc. | -37.21 Million USD | -5351.537% |
| bluebird bio, Inc. | 108.57 Million USD | 1968.679% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -157432.031% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 635.671% |
| DBV Technologies S.A. | -126.98 Million USD | -1497.691% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -157432.031% |
| Moderna, Inc. | -2.9 Billion USD | 30.208% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -19498.57% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -18568.053% |
| Molecular Templates, Inc. | 707 Thousand USD | 287065.205% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -6367.26% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 685.343% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -2372.331% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -2111.756% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -6186.701% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -5801.92% |
| MacroGenics, Inc. | -66.98 Million USD | -2928.803% |
| RenovoRx, Inc. | -1.17 Million USD | -172861.978% |
| Adicet Bio, Inc. | -138.78 Million USD | -1361.84% |
| Prime Medicine, Inc. | -27.94 Million USD | -7161.172% |
| Aditxt, Inc. | 18.12 Million USD | 11296.164% |
| Adagene Inc. | -87.62 Million USD | -2215.308% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -48606.736% |
| Quantum-Si incorporated | -118.55 Million USD | -1611.281% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 5734.895% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -27044.674% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -4082.407% |
| SciSparc Ltd. | -2.06 Million USD | -98149.104% |
| Vericel Corporation | 1.27 Million USD | 158975.803% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -16818.734% |
| Minerva Neurosciences, Inc. | 41 Million USD | 5047.887% |
| Generation Bio Co. | 31.44 Million USD | 6551.425% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -1056.933% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -6460.955% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 1840.108% |
| Invivyd, Inc. | -198.47 Million USD | -922.211% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -2147.529% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -84516.671% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -2766.004% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -29626.652% |
| 2seventy bio, Inc. | 181.71 Million USD | 1216.498% |
| ADMA Biologics, Inc. | 90.06 Million USD | 2352.619% |
| Clene Inc. | 3.34 Million USD | 60843.832% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -22237.447% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -9331.658% |
| GeoVax Labs, Inc. | -6.45 Million USD | -31342.325% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -489.568% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -7703.341% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 1241.943% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -49485.99% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 40660.656% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -38848.819% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -1457.008% |
| Evaxion Biotech A/S | 5.28 Million USD | 38475.333% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -1702.327% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -1445.515% |
| Trevena, Inc. | 2.25 Million USD | 89951.373% |
| Surrozen, Inc. | -32.66 Million USD | -6111.254% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -3838.738% |
| Cingulate Inc. | 3.08 Million USD | 65914.227% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -68978.788% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 28329.359% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -21736.126% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -2457.7% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -1443.411% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -1822.31% |
| Clearmind Medicine Inc. | -3.94 Million USD | -51359.062% |
| Kronos Bio, Inc. | -36.05 Million USD | -5527.237% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 21662.802% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 139240.418% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -3639.391% |
| Statera Biopharma, Inc. | 14.41 Million USD | 14173.161% |
| ImmunityBio, Inc. | 618.22 Million USD | 428.173% |
| Korro Bio, Inc. | -132.94 Million USD | -1426.101% |
| Kineta, Inc. | -4.54 Million USD | -44578.353% |
| BioVie Inc. | -17.73 Million USD | -11341.483% |
| Codexis, Inc. | -43.27 Million USD | -4588.692% |
| Celularity Inc. | 65.19 Million USD | 3212.201% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -63921.584% |
| Celcuity Inc. | 6.78 Million USD | 30008.474% |
| Virax Biolabs Group Limited | -3.36 Million USD | -60193.544% |
| Cibus, Inc. | -8.07 Million USD | -25015.672% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -47874.557% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 44494.836% |
| IN8bio, Inc. | -16.38 Million USD | -12279.303% |
| Kodiak Sciences Inc. | -103.87 Million USD | -1853.159% |
| Annexon, Inc. | -193.75 Million USD | -947.118% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 5635777.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -11494.057% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -57652.462% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 292.44% |
| Eyenovia, Inc. | 1.25 Million USD | 161285.412% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 7640.769% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -62460.715% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -6002.337% |
| Arcellx, Inc. | -296.95 Million USD | -583.209% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -10301.128% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -3346.02% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -9688.411% |
| Moolec Science SA | 117.61 Thousand USD | 1725072.793% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -5183.586% |
| Geron Corporation | 14.76 Million USD | 13844.624% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -5250.609% |
| Royalty Pharma plc | 5.65 Billion USD | 135.856% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -1334.613% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -28927.342% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -37731.388% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -1341.647% |
| Humacyte, Inc. | -22.48 Million USD | -8922.699% |
| Structure Therapeutics Inc. | -124.33 Million USD | -1531.703% |
| 89bio, Inc. | -289.05 Million USD | -601.893% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -7937.572% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -113688.222% |
| Genelux Corporation | -6.89 Million USD | -29307.798% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -6432.226% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 2526.876% |
| Notable Labs, Ltd. | -9.77 Million USD | -20653.314% |
| Liquidia Corporation | -80.17 Million USD | -2430.488% |
| Mustang Bio, Inc. | -3.73 Million USD | -54205.246% |
| Immunovant, Inc. | -635.22 Million USD | -219.389% |
| Quantum-Si incorporated | -118.55 Million USD | -1611.281% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -11451.15% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -48870.408% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 25375.246% |
| Acasti Pharma Inc. | -23 Million USD | -8719.144% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -60152.629% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -12385.676% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -1372.952% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -65002.963% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -9025.783% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -10825.973% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -1098.528% |
| PepGen Inc. | -60.67 Million USD | -3244.065% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -8730.275% |
| United Therapeutics Corporation | -507.7 Million USD | -299.615% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -10507.78% |
| Solid Biosciences Inc. | -47.75 Million USD | -4148.888% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -235240.435% |
| Immuneering Corporation | -54.94 Million USD | -3592.644% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -48165.726% |
| Silo Pharma, Inc. | -3.52 Million USD | -57467.159% |
| Belite Bio, Inc | -87.27 Million USD | -2224.763% |
| XOMA Corporation | -29 Million USD | -6896.014% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -2769.774% |
| Bionomics Limited | 227 Million USD | 993.725% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -1644.762% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -79996.486% |
| uniQure N.V. | -102.95 Million USD | -1870.689% |
| Cassava Sciences, Inc. | -121.13 Million USD | -1574.848% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -48606.736% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 5054.321% |
| Forte Biosciences, Inc. | -11.96 Million USD | -16862.16% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -65469.259% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 1914103.774% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -62460.715% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 22883.2% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -27257.659% |
| Altimmune, Inc. | -134.48 Million USD | -1408.58% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 1124.332% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -79996.486% |
| Compugen Ltd. | -12.9 Million USD | -15622.598% |
| Peak Bio, Inc. | 10.34 Million USD | 19721.015% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -716806.007% |
| Benitec Biopharma Inc. | -50.58 Million USD | -3911.0% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -1844.492% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 10427.534% |
| Zura Bio Limited | -99.8 Million USD | -1932.788% |
| PolyPid Ltd. | 6.17 Million USD | 32982.399% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 2837.242% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 10427.534% |
| Instil Bio, Inc. | 75.35 Million USD | 2792.274% |
| Immunome, Inc. | -97.02 Million USD | -1990.967% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -8919.089% |
| Verona Pharma plc | -220.44 Million USD | -820.349% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -2727.933% |
| Shattuck Labs, Inc. | -121.42 Million USD | -1570.876% |
| CervoMed Inc. | -7.79 Million USD | -25934.699% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -993.722% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -46294.786% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -1440.036% |
| Moolec Science SA | 117.61 Thousand USD | 1725072.793% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -88574.143% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 12861.325% |
| AnaptysBio, Inc. | -18.15 Million USD | -11077.588% |
| Design Therapeutics, Inc. | -18.15 Million USD | -11078.204% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -2782.659% |
| NeurAxis, Inc. | 145.7 Thousand USD | 1392580.439% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 18163.07% |
| Lumos Pharma, Inc. | -28.49 Million USD | -7020.5% |
| Achilles Therapeutics plc | -126.92 Million USD | -1498.472% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -2727.933% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -309302.345% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -9666.348% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 139240.418% |
| Nutriband Inc. | -251.65 Thousand USD | -806094.145% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -15303.872% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -27169.409% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 696.373% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 8647.9% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -353.402% |
| Palisade Bio, Inc. | -12.06 Million USD | -16718.735% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -1345.962% |
| Beam Therapeutics Inc. | -262.72 Million USD | -672.24% |
| Neurogene Inc. | -131.95 Million USD | -1437.527% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 9399.798% |
| AEON Biopharma, Inc. | -4.88 Million USD | -41474.672% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -437.882% |
| Sesen Bio, Inc. | -112.55 Million USD | -1702.568% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -1931.688% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -86314.944% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -5098.698% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -2336.113% |
| Athira Pharma, Inc. | -88.99 Million USD | -2179.626% |
| Vaccinex, Inc. | -1.28 Million USD | -157418.944% |
| HCW Biologics Inc. | 2.85 Million USD | 71121.145% |
| XOMA Corporation | -29 Million USD | -6896.014% |
| Nektar Therapeutics | 210.24 Million USD | 1065.013% |
| Arvinas, Inc. | -313.8 Million USD | -546.54% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 125114.265% |
| Merus N.V. | -192.88 Million USD | -951.847% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 3482.252% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -29142.491% |
| Rezolute, Inc. | -68.16 Million USD | -2876.241% |
| Clene Inc. | 3.34 Million USD | 60843.832% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -15285.182% |
| BeyondSpring Inc. | -13.75 Million USD | -14649.866% |
| Synlogic, Inc. | -6.68 Million USD | -30249.2% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 179010.406% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -23895.789% |
| Peak Bio, Inc. | 10.34 Million USD | 19721.015% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -2361.592% |
| Krystal Biotech, Inc. | -350.23 Million USD | -479.282% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 1734.517% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -1100.528% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -64162.004% |
| MannKind Corporation | 143.89 Million USD | 1509.908% |
| Ikena Oncology, Inc. | -109.15 Million USD | -1758.665% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -26697.57% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -6029.438% |
| Gossamer Bio, Inc. | 180.35 Million USD | 1224.917% |
| CohBar, Inc. | -5.93 Million USD | -34109.004% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -6720.102% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 44533.728% |
| Legend Biotech Corporation | -949.39 Million USD | -113.698% |
| Mural Oncology plc | -255.84 Million USD | -693.004% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 6397.824% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -42969.374% |
| Disc Medicine, Inc. | -358.28 Million USD | -466.272% |
| Champions Oncology, Inc. | 4.81 Million USD | 42262.178% |
| REGENXBIO Inc. | 54.76 Million USD | 3804.433% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -754377.942% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -1243.392% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -22412.679% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -2414.587% |
| Vaxart, Inc. | -8.24 Million USD | -24518.905% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -3943.135% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -1495.434% |
| Cellectis S.A. | -43.85 Million USD | -4526.255% |
| Longeveron Inc. | -2.9 Million USD | -69667.675% |
| Repare Therapeutics Inc. | -107.85 Million USD | -1781.032% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 309.51% |
| Inozyme Pharma, Inc. | 12 Million USD | 17001.4% |
| Revolution Medicines, Inc. | -608.2 Million USD | -233.58% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -164846.667% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -665.264% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -1251.914% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -12866.345% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -274068.108% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 78.786% |
| Denali Therapeutics Inc. | -74.86 Million USD | -2610.003% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -16818.734% |
| Veru Inc. | 4.77 Million USD | 42544.71% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -17940.583% |
| Cingulate Inc. | 3.08 Million USD | 65914.227% |
| Passage Bio, Inc. | 4.58 Million USD | 44349.597% |
| Context Therapeutics Inc. | -14.44 Million USD | -13940.611% |
| Exicure, Inc. | 5.84 Million USD | 34787.023% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -780.666% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -5027.228% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 13029.985% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -3349.183% |
| Nuvalent, Inc. | -335.38 Million USD | -504.926% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 117080.686% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -2623.939% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -22721.642% |
| OmniAb, Inc. | 9.2 Million USD | 22145.463% |
| Anew Medical, Inc. | 1.43 Million USD | 141733.059% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 12484.778% |
| Lipocine Inc. | -4.75 Million USD | -42571.253% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -1747.292% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 13420.491% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -3904.903% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 8250.587% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -30086.639% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -2982.085% |
| Ocugen, Inc. | -32.52 Million USD | -6138.566% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -2270.837% |
| Q32 Bio Inc. | -37.94 Million USD | -5246.379% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -322964.331% |
| Alumis Inc. Common Stock | -13.52 Million USD | -14896.26% |
| Equillium, Inc. | -22.39 Million USD | -8960.575% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -7835.091% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -6118.342% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -818262.745% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 1613.588% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 63541.026% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 617819.469% |
| Dominari Holdings Inc. | 195 Thousand USD | 1040532.821% |
| Edesa Biotech, Inc. | -5.26 Million USD | -38420.575% |
| vTv Therapeutics Inc. | -8.91 Million USD | -22652.54% |
| Bio-Techne Corporation | 267.74 Million USD | 857.747% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -12416.775% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -1617.991% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -24044.282% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -15937.025% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -727.698% |
| Nkarta, Inc. | 57.29 Million USD | 3640.802% |
| BioCardia, Inc. | 212 Thousand USD | 957101.887% |
| Iterum Therapeutics plc | 13.43 Million USD | 15197.812% |